WHITE PAPER | MEDTECH
China MedTech – Navigating the Road Ahead
November 15, 2025 12:00 AM UTC
In its annual report, McKinsey’s analysis examines how China’s healthcare ecosystem is evolving across biopharma and medtech.
Topics Discussed
Additional Insights from McKinsey & Company:
- The balance between best-in-class and first-in-class innovation
- Shifts in commercial and market access models
- Cross-border investment and licensing dynamics
- Emerging pathways for sustainable biotech and medtech growth